Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMRODZS)

Drug Name

PV-707 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Skin burns	ME65.0	Discontinued in Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Receptor unspecific (Rec)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ATL-104	DMD0I29	Solid tumour/cancer	2A00-2F9Z	Phase 2	[3]
Prosaptide TX14(A)	DME25TI	Neuropathic pain	8E43.0	Phase 2	[4]
Lactermin	DM8ANIM	Oral mucositis	DA01.11	Phase 1	[5]
BT-063	DMS4H30	Autoimmune diabetes	5A10	Phase 1	[6]
YP-004	DMK1UJM	Solid tumour/cancer	2A00-2F9Z	Terminated	[7]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016102)
2	EP patent application no. 1904089, Promotion of epithelial regeneration.
3	Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplant. 2009 Apr;43(7):563-9.
4	Central action of prosaptide TX14(A) against gp120-induced allodynia in rats. European Journal of Pain Volume 12, Issue 1, January 2008, Pages 76-81.
5	Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci. 2005 Nov;62(22):2560-75.
6	Clinical pipeline report, company report or official report of Biotest.
7	CA patent application no. 815512, Method for increasing the efficiency of double-strand break-induced mutagenesis.